title: Monitoring Anticoagulation During Percutaneous Coronary Interventions.
abstract: Monitoring of the activated clotting time in the interventional catheterization suite is essential to minimize the risk of acute thrombotic occlusion, as well as to minimize the risk of bleeding-related complications postprocedure. Based on the technique used, a Hemochron ACT of >400 seconds or a HemoTec ACT of >300 seconds is associated with a low risk of acute thrombotic occlusion. Avoiding an ACT of >500 seconds should minimize the risk of procedure-related bleeding complications.
authors.affiliation: Cardiac Catheterization Laboratory, Mail Stop-119, Hahnemann University Hospital, Philadelphia, PA 19102-1192.
authors.initials: M
authors.lastname: Cohen